One License for Two Therapeutic Antibody Discovery Platforms
Biocytogen’s RenMab™ and RenLite™ mice are powerful platforms for fully human therapeutic antibody discovery. The RenMab™ model, our best-in-class model, is ideal for discovery of fully human therapeutic antibodies. The RenLite™ model is specially designed for bispecific and multispecific antibody discovery. One license covers use of both platforms.